Enovis Corporation (0I1B.L)
| Previous close | 51.72 |
| Open | 51.07 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 51.07 - 51.07 |
| 52-week range | 43.31 - 65.36 |
| Volume | |
| Avg. volume | 26 |
| Market cap | N/A |
| Beta (5Y monthly) | 2.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Zacks5 Medical Info Systems Stocks to Buy for Stable Returns
We have narrowed our search to five medical info systems stocks that have strong growth potential for 2024. These stocks are: HIMS, BFLY, ENOV, LUNG, DH.
GlobeNewswireEnovis to Participate in Upcoming Investor Conferences
Wilmington, DE, May 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Bank of America Healthcare Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, May 15th at 4:20 p.m. Pacific Time.William Blair Growth Stock Conference: Matt Trerotola, Chair and Chief Executive Officer, will particip
ZacksHere's Why Enovis (ENOV) is Poised for a Turnaround After Losing -17.45% in 4 Weeks
Enovis (ENOV) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
